CVR 38704001Private limited company (ApS)Forskning og eksperimentel udvikling indenfor bioteknologi (721100)Smedeland 7, 2600 GlostrupFounded 12 Jun 2017
Bifrost Biolabs ApS
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Bifrost Biolabs ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, 2022
Gross profit
-90.6K
DKK, annual report Dec 2021
Result
-422K
DKK, annual report Dec 2021
Equity
-381.8K
DKK, annual report Dec 2021
Madapofo Holding ApSCVR 39279746, 20% to under 25% of capital and votes, until 26 Jul 2023
JMMSM HOLDING IVSCVR 39884879, 20% to under 25% of capital and votes, until 26 Jul 2023
and 1 morePoul Foghuntil 20 Jul 2022
No current owner is registered.
100% of capital and votesnotified 23 Aug 201712 Jun 2017 to 23 Aug 2017
CVR 3870343933.3% to under 50% of capital and votesnotified 31 Dec 201923 Aug 2017 to 26 May 2022
CVR 3927974620% to under 25% of capital and votes24 Oct 2018 to 26 Jul 2023
CVR 3988487920% to under 25% of capital and votes24 Oct 2018 to 26 Jul 2023
CVR 4039829515% to under 20% of capital and votesnotified 31 Dec 201915 Jul 2019 to 26 Jul 2023
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Jun 2022, monthly: 1 employee, 0 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 |
| FTE | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Jun 2022, published 23 Aug 2022.
The company's own figures, in DKK, from the annual reports filed in XBRL.
Dec 2021, DKK: Gross profit -90.6K, Operating profit -421.5K, Result for the year -422K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
Dec 2021, DKK: Total assets 30.9K, Equity -381.8K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | Mar 2018 | Mar 2019 | Mar 2020 | Dec 2020 | Dec 2021 |
|---|---|---|---|---|---|
| Gross profit | Not reported | Not reported | Not reported | 370 | -91 |
| Operating profit | +34 | -6 | -83 | +74 | -421 |
| Result for the year | +27 | -6 | -83 | +70 | -422 |
| Equity | 27 | 23 | -29 | 40 | -382 |
| Total assets | 46 | 276 | 82 | 249 | 31 |
| Employees (average) | Not reported | 1 | 1 | 2 | 1 |
Not every period is a full year: Mar 2018 covers 10 months (12 Jun 2017 to 31 Mar 2018) and Dec 2020 covers 9 months (1 Apr to 31 Dec 2020). Changes against them compare periods of different length.
Annual report Dec 2021
Published 11 Jul 2022
Annual report Dec 2020
1 Apr 2020 to 31 Dec 2020, published 14 Jul 2021
Annual report Mar 2020
1 Apr 2019 to 31 Mar 2020, published 15 May 2020
Annual report Mar 2019
1 Apr 2018 to 31 Mar 2019, published 28 May 2019
Annual report Mar 2018
12 Jun 2017 to 31 Mar 2018, published 23 Aug 2018
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseBonus issue from reserves | None | None | None | 40,635 | |
| IncreaseNot read from the announcement | None | None | None | 2 | |
| IncreaseNot read from the announcement | None | None | None | 2 | |
| FoundingCashPaid in 1 | None | 1 | None | 1 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital. 2 steps could not be read that way and stand as registered.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | Mar 2018 | Mar 2019 | Mar 2020 | Dec 2020 | Dec 2021 |
|---|---|---|---|---|---|
| EBITDA | Not reportednote 1 | Not reportednote 1 | -79 | 78 | -228 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reportednote 2 | Not reportednote 2 | 32note 3 | 134note 3 | 0note 3 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 20 Nov 2026.
15 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Konkursbehandlingen afsluttet 26.07.2023, virksomheden opløst
Konkursdekret afsagt 14.10.2022 af Sø- og Handelsrettens Skifteretsafdeling
Likvidatorer:
Fratrådte:
Marianne Philip, den 14.10.2022.
Revision:
Likvidatorer:
Tiltrådte:
Sø- og Handelsrettens Skifteretsafdeling har udnævnt følgende likvidatorer: Marianne Philip, 2100 København Ø, den 09.09.2022.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 19.08.2022
Bestyrelse:
Fratrådte:
Poul Fogh, (formand), den 19.08.2022, Hasse Hedeby, den 19.08.2022, Jesper Møller, den 19.08.2022.
Direktion:
Fratrådte:
Poul Fogh, (adm. dir), den 20.07.2022.
Bestyrelse:
Fratrådte:
Poul Fogh, den 29.06.2022, Lasse Blirup Snejbjerg, (formand), den 29.06.2022.
Tiltrådte:
Poul Fogh, (formand), den 29.06.2022.
Direktion:
Fratrådte:
Poul Fogh, den 29.06.2022, Lasse Blirup Snejbjerg, (adm. dir), den 29.06.2022.
Tiltrådte:
Poul Fogh, (adm. dir), den 29.06.2022.
Virksomheden er omregistreret fra Iværksætterselskab til Anpartsselskab
Vedtægter ændret: 30.12.2020
Nyt navn: Bifrost Biolabs ApS
Slettet binavn: Recombiotics IVS
Kapitalforhøjelsen er besluttet den 30.12.2020.
kr. 40.633,11, indbetalt ved overførte reserver / overskud, kurs 100,00.
Kapitalen udgør herefter kr. 40.635,00.
Bestyrelse:
Fratrådte:
Vilhelm Krarup Møller, den 30.12.2020.
Direktion:
Fratrådte:
Hasse Hedeby, den 30.12.2020, Jesper Møller, den 30.12.2020.
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af den samlede Bestyrelse.
Regnskabsår ændret til: 01.01 - 31.12
Omlægningsperiode: 01.04.2020 - 31.12.2020
Formål ændret: Selskabets formål er at drive virksomhed med at udvikle automatiseringsudstyr til den biologiske industri og hermed forbundet virksomhed.
Bestyrelse:
Fratrådte:
Vilhelm Krarup Møller, (formand), den 26.11.2020.
Tiltrådte:
Vilhelm Krarup Møller, den 26.11.2020, Lasse Blirup Snejbjerg, (formand), den 26.11.2020.
Direktion:
Fratrådte:
Vilhelm Krarup Møller, (adm. dir), den 26.11.2020.
Tiltrådte:
Lasse Blirup Snejbjerg, (adm. dir), den 26.11.2020.
Ny adresse: c/o Bifrost Biolabs, Smedeland 7, 1., Smedeland, 2600 Glostrup
Ny kommune: Albertslund
Bestyrelse:
Fratrådte:
Jan Schouenborg Dombernowsky, den 24.10.2019.
Vedtægter ændret: 08.07.2019
Kapitalforhøjelsen er besluttet den 08.07.2019.
kr. ,19, indbetalt kontant, kurs 15.873.000,15.
Kapitalen udgør herefter kr. 1,89.
Bestyrelse:
Tiltrådte:
Jan Schouenborg Dombernowsky, den 15.07.2019, Poul Fogh, den 15.07.2019, Hasse Hedeby, den 15.07.2019, Jesper Møller, den 15.07.2019.
Direktion:
Tiltrådte:
Poul Fogh, den 15.07.2019, Hasse Hedeby, den 15.07.2019, Jesper Møller, den 15.07.2019.
Ny adresse: c/o Bifrost Biolabs, Ole Maaløes Vej 3, 3., 2200 København N
Vedtægter ændret: 19.03.2019
Nyt navn: Bifrost Biolabs IVS
Nyt binavn: Recombiotics IVS
Vedtægter ændret: 24.10.2018
Kapitalforhøjelsen er besluttet den 24.10.2018.
kr. ,70, indbetalt kontant, kurs 294.117,65.
Kapitalen udgør herefter kr. 1,70.
Ny adresse: c/o Marie Soelberg, Küchlersgade 35, 1774 København V
Ny kommune: København
Stiftelsesdato: 12.06.2017.
Virkningsdato: 12.06.2017.
Seneste vedtægtsdato: 12.06.2017.
Kapital:
kr. 1,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 1,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 38703439 VKM Holding IVS, Nybrovej 304, 2800 Kgs. Lyngby, den 12.06.2017.
Bestyrelse:
Vilhelm Krarup Møller (formand), den 12.06.2017.
Direktion:
Vilhelm Krarup Møller (adm. dir), den 12.06.2017.
Virksomheden tegnes af direktionen..
Første regnskabsår:
12.06.2017 - 31.03.2018.
Regnskabsår:
01.04 - 31.03.
Formål:
The company focuses on research and production of biobased chemicals.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for Bifrost Biolabs ApS:
Have Pro? Sign in.
P-number 1022515043Smedeland 7, 2600 Glostrup